About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Colorectal Cancer Clinical Trials | 6,423 Studies Recruiting

Clinical TrialsColorectal Cancer

Colorectal Cancer Clinical Trials

Browse 6,423 clinical trials for colorectal cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5661-5680 of 6,423 trials

CompletedImmune Response in Peripheral Blood of Patients With Colon CancerRATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that may occur in the immune system that may help kill…NCT00900432·Tucson, Arizona UnknownManagement of Metastatic Colorectal Cancer: A Clinical and Patient PerspectiveA Real World Evidence Prospective Cohort Study in the Management of Metastatic Colorectal Cancer: A Clinical and Patient PerspectiveNCT03935763·Buenos Aires and 17 others UnknownClinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid BiopsyGastric cancer and colorectal cancer are common gastrointestinal malignancies in the world.Early cancer generally has no obvious symptoms.NCT04385316·Nanjing, Jiangsu

Related Searches

colon cancertrials rectal cancertrials

Data from ClinicalTrials.govTerms

UnknownEffects of Abdominal Nerve Block on Postoperative Recovery in Patients Undergoing Gastrointestinal SurgeryTo explore the effect of general anesthesia combined with transversus abdominis plane block (TAPB) and/or rectus sheath block (RSB) on the recovery of patients with…NCT04147481·Beijing, Haidian

UnknownFruquintinib as a Maintenance Therapy Following First-line Treatment for Metastatic Colorectal CancerThis study was a randomized, controled, multicenter, phase II clinical study evaluating the efficacy and safety of fruquintinib as a maintenance therapy following first-line…NCT04296019·Shanghai, Shanghai Municipality

CompletedFOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-typeBACKGROUND: For patients with liver-limited metastatic colorectal cancer (mCRC), complete resection of liver metastases is the only potentially curative treatment.NCT02350530·Guangzhou, Guangdong

CompletedS1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal CancerThis randomized phase II trial studies how well irinotecan hydrochloride and cetuximab with or without vemurafenib works in treating patients with colorectal cancer that has…NCT02164916·Anchorage, Alaska and 762 others

TerminatedStudy of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)The purpose of this study is to evaluate the safety and tolerability of humanized IgG4 (kappa) isotype monoclonal antibody against CEACAM1 (CM-24 \[MK-6018\]), administered…NCT02346955·Los Angeles, California and 2 others

Not yet recruitingThe Canopy Cancer Collective Clinical Registry ProtocolThe Canopy Cancer Collective Clinical Registry Protocol Non-Interventional Data and Sample Collection Registry Protocol Number of study sites 15 Study Design - Observational…NCT07605702·San Diego, California and 9 others

UnknownA Multi-center Trial to Establish a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNAIn this study, the investigators establish a model for the early diagnosis of colorectal cancer based on the detection of 5-hydroxymethylcytosine (5-hmC) in training group and…NCT03676075·Shanghai, Shanghai Municipality

CompletedCompliance With ERAS and Five Year Survival After Colorectal Cancer TreatmentThe Enhanced Recovery after Surgery (ERAS) protocol has transformed perioperative care, representing a significant paradigm shift in managing colorectal cancer patients.NCT06342687·Krakow, Lesser Poland Voivodeship

Not yet recruitingHepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesThis is a prospective, single-center, single-arm exploratory clinical study designed to evaluate the efficacy and safety of hepatic arterial infusion of liposomal irinotecan…NCT07570914

Active not recruitingEffectiveness of Fecal Immunnochemical Test and Colonoscopy Screening in Hong KongColorectal neoplasm in Asia is now increasingly common and is rising in an alarming manner in Hong Kong.NCT03597204·Hong Kong

CompletedImmunotherapy in Treating Patients With Resected Liver Metastases From Colon CancerRATIONALE: Immunotherapy using CEA-treated white blood cells may help a person's body build an immune response to kill their tumor cells.NCT00003433·Durham, North Carolina

TerminatedA Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerTC-510 is a novel cell therapy that consists of autologous genetically engineered T cells expressing two synthetic constructs: first, a single-domain antibody that recognizes…NCT05451849·San Franciso, California and 6 others

CompletedCirculating Tumor Material in Colorectal Cancer and MelanomaObservational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanomaNCT02907086·Philadelphia, Pennsylvania

CompletedA Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic ServicesThe goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services.NCT02517554·Elkton, Maryland and 6 others

UnknownA Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRIThis study evaluates the combination of SCO-101 to FOLFIRI for the treatment of metastatic colorectal cancer patients who have developed resistance to FOLFIRI treatment.NCT04247256·Aalborg and 11 others

TerminatedStudy to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.A phase 1, open-label, dose escalation and expansion study of PF-07062119 in patients with selected advanced or metastatic gastrointestinal tumorsNCT04171141·Duarte, California and 18 others

UnknownFOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal CancerTo observe and evaluate the efficacy and safety of FOLFOX/FOLFIRI± target-directed regimen containing Levofolinic Acid (Zuoyu ®) in first-line treatment of unresectable or…NCT05797883·Shenyang, Liaoning

PreviousPage 284 of 322Next